Select conditions we are targeting:

ARDS [Acute Respiratory Distress Syndrome]

Our lung drug will be the first to block the root cause of inflammation associated with ARDS
Find out how

Select conditions we are targeting:

ARDS [Acute Respiratory Distress Syndrome]

Our lung drug will be the first to block the root cause of inflammation associated with ARDS
Find out how

IBD [Inflammatory Bowel Disease]

Our IBD drug will block GI inflammation and eliminate its consequences.
Find out how

IBD [Inflammatory Bowel Disease]

Our IBD drug will block GI inflammation and eliminate its consequences.
Find out how

DFU [Diabetic Foot Ucers]

Our drug for non-healing wounds will halt the inflammatory cascade and restore natural healing.
Find out how

DFU [Diabetic Foot Ucers]

Our drug for non-healing wounds will halt the inflammatory cascade and restore natural healing.
Find out how
Restoring Natural Healing.

Recovering from injury and infection through the body’s inflammatory process is the norm, but sometimes inflammation can become uncontrolled. Unregulated inflammation is proven causal to several acute and chronic conditions and diseases. By boosting the body’s innate ability to regulate inflammation–the consequences of inflammation are eliminated, and tissues can heal normally.

Ceria Therapeutics develops innovative drug products for inflammatory disorders. We intend to transform lives by eliminating the consequences of inflammation and resolving disease itself.

Our Science
Restoring Natural Healing.

Recovering from injury and infection through the body’s inflammatory process is the norm, but sometimes inflammation can become uncontrolled. Unregulated inflammation is proven causal to several acute and chronic conditions and diseases. By boosting the body’s innate ability to regulate inflammation–the consequences of inflammation are eliminated, and tissues can heal normally.

Ceria Therapeutics develops innovative drug products for inflammatory disorders. We intend to transform lives by eliminating the consequences of inflammation and resolving disease itself.

Our Science

LATEST NEWS

Ceria Therapeutics, Inc. Awarded a $2,000,000 SBIR Grant to Advance Development of a Novel Treatment for Non-healing Diabetic Foot Ulcers

Go to article

Ceria Therapeutics, Inc. Awarded a $3,800,000 DoD Contract to Advance Development of a Novel Treatment for Acute Lung Injuries

Go to article

Photopolymerized Zwitterionic Hydrogels with a Sustained Delivery of Cerium Oxide Nanoparticle-miR146a Conjugate Accelerate Diabetic Wound Healing

Go to article
LATEST NEWS

Ceria Therapeutics, Inc. Awarded a $2,000,000 SBIR Grant to Advance Development of a Novel Treatment for Non-healing Diabetic Foot Ulcers

Go to article

Ceria Therapeutics, Inc. Awarded a $3,800,000 DoD Contract to Advance Development of a Novel Treatment for Acute Lung Injuries

Go to article

Photopolymerized Zwitterionic Hydrogels with a Sustained Delivery of Cerium Oxide Nanoparticle-miR146a Conjugate Accelerate Diabetic Wound Healing

Go to article

CONTACT US